Effect of Opioids on Testosterone Levels: Cross-Sectional Study using NHANES

被引:20
作者
Cepeda, Maria Soledad [1 ]
Zhu, Vivienne [1 ]
Vorsanger, Gary [2 ]
Eichenbaum, Gary [3 ]
机构
[1] Janssen Res & Dev LLC, Dept Epidemiol, Titusville, NJ 08560 USA
[2] Janssen Res & Dev LLC, US Med Affairs, Titusville, NJ 08560 USA
[3] Johnson & Johnson, Off Chief Med Officer, New Brunswick, NJ 08901 USA
关键词
Opioids; Testosterone; Age; Comorbidities; National Health and Nutrition Examination Survey; MIDDLE-AGED MEN; HYPOGONADISM; SUPPRESSION; PREVALENCE;
D O I
10.1111/pme.12843
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. Opioids can suppress gonadal hormone production, which may result in low testosterone levels. To date, there have been no large-scale population-based studies examining the extent to which opioid use may contribute to changes in testosterone levels. Design. Cross-sectional study. Setting. 2011-2012 National Health and Nutrition Examination Survey. Subjects. Participants 17 years and older who had data on prescription medication usage and serum testosterone levels available. Participants were divided in two groups, opioid exposed and unexposed. Methods. Testosterone levels of participants who responded that they had been exposed (n = 320) to prescription opioids in the past 30 days were compared with those who were unexposed (n = 4909). The number of participants with low testosterone levels was calculated and unadjusted and adjusted analyses were performed. Results. Participants on opioids had higher odds of having low testosterone levels than those unexposed, odd ratio (OR) = 1.40, 95% confidence interval (CI) (1.07-1.84). After controlling for opioid exposure, as the age and the number of comorbidities increased, the odds of having low testosterone levels significantly increased in all categories. Compared with participants between 17 and 45 years of age, participants >70 years had OR = 1.70, 95% CI (1.16-2.50). Compared with participants with no comorbidities, participants with >2 comorbidities had OR = 1.69 95% CI (1.24-2.30). Conclusion. When assessing the impact of opioids on testosterone, the effects of age and medical conditions should be considered.
引用
收藏
页码:2235 / 2242
页数:8
相关论文
共 26 条
[1]   Endocrine consequences of long-term intrathecal administration of opioids [J].
Abs, R ;
Verhelst, J ;
Maeyaert, J ;
Van Buyten, JP ;
Opsomer, F ;
Adriaensen, H ;
Verlooy, J ;
Van Havenbergh, T ;
Smet, M ;
Van Acker, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06) :2215-2222
[2]   Methadone induces testosterone suppression in patients with opioid addiction [J].
Bawor, Monica ;
Dennis, Brittany B. ;
Samaan, M. Constantine ;
Plater, Carolyn ;
Worster, Andrew ;
Varenbut, Michael ;
Daiter, Jeff ;
Marsh, David C. ;
Desai, Dipika ;
Steiner, Meir ;
Anglin, Rebecca ;
Coote, Margaret ;
Pare, Guillaume ;
Thabane, Lehana ;
Samaan, Zainab .
SCIENTIFIC REPORTS, 2014, 4
[3]   HEROIN-ADDICTION - RELATIONSHIP BETWEEN THE PLASMA-LEVELS OF TESTOSTERONE, DIHYDROTESTOSTERONE, ANDROSTENEDIONE, LH, FSH, AND THE PLASMA-CONCENTRATION OF HEROIN [J].
BOLELLI, G ;
LAFISCA, S ;
FLAMIGNI, C ;
LODI, S ;
FRANCESCHETTI, F ;
FILICORI, M ;
MOSCA, R .
TOXICOLOGY, 1979, 15 (01) :19-29
[4]  
Centers for Disease Control and Prevention, 2022, J Korean Med Sci
[5]  
Centers for Disease Control and Prevention, SURV DES FACT COURS
[6]  
Colameco S, 2009, J AM OSTEOPATH ASSOC, V109, P20
[7]   Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain [J].
Daniell, Harry W. .
JOURNAL OF PAIN, 2008, 9 (01) :28-36
[8]   Hypogonadism in men consuming sustained-action oral opioids [J].
Daniell, HW .
JOURNAL OF PAIN, 2002, 3 (05) :377-384
[9]  
De Maddalena C, 2012, PAIN PHYSICIAN, V15, pES111
[10]  
Eichenbaum Gary, 2015, J Opioid Manag, V11, P211, DOI 10.5055/jom.2015.0270